Fleisher, Mark R. External Entity

Publications

Sort by

Selected publications

  • A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.  Gastroenterology2008 Academic Article GET IT

Other